← European Medicine Shortage Tracker · all medicines
Olmesartan and hydrochlorothiazide currently has availability issues reported in 1 European register: Greece.
Limited availability ATC C09DA08 · also listed as: Olmesartan and hydrochlorothiazide · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Olmesartan and hydrochlorothiazide, covering 3 affected product presentations. The longest-running open report was filed in Greece on 2025-09-03 and has now been open for about 11 months. Where agencies state a cause, delivery delays lead with 3 of the 3 stated-cause reports. The furthest expected-resolution date currently on file is 2026-10-31; the earliest is 2026-10-31. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Greece indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Olmesartan and hydrochlorothiazide is coded C09DA08 — a medicine acting on the cardiovascular system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇬🇷 Greece | Limited availability BTx30 tabs (blister PVC/PVDC/AL) + 2 more productsBTx30 tabs (blister PVC/PVDC/AL) OLMETEC-PLUS F.C.TAB (40+12,5)MG/TAB BT x 28 | 2025-09-03 | 2026-10-31 | Καθυστέρηση παράδοσης ίδιων περιεκτικοτήτων Εναλλακτικά άλλα σκευάσματ Alternatives: Εναλλακτικά άλλα σκευάσματα των ίδιων δραστικών, της ίδιας μορφής και | register ↗ |
Every individual register entry for Olmesartan and hydrochlorothiazide in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | BTx30 tabs (blister PVC/PVDC/AL) | Limited availability | 2026-06-29 | 2026-10-31 | Καθυστέρηση παράδοσης ίδιων περιεκτικοτήτων Προβλήματα στην |
| 🇬🇷 GR | OLMETEC-PLUS F.C.TAB (40+12,5)MG/TAB BT x 28 | Limited availability | 2026-04-29 | 2026-07-31 | ΦΑΡΜΑΣΕΡΒ ΕΛΛΑΣ Α.Ε.Β.Ε., ΕΛΛΑΔΑ Καθυστέρηση παράδοσης ίδιων |
| 🇬🇷 GR | BTx30 tabs (blister PVC/PVDC/AL) | Limited availability | 2025-09-03 | 2026-07-17 | Καθυστέρηση παράδοσης ίδιων περιεκτικοτήτων Εναλλακτικά άλλα |
Yes. As of 7 August 2026, availability issues are reported in: Greece. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-31 to 2026-10-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Olmesartan and hydrochlorothiazide: EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Olmesartan and hydrochlorothiazide — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/olmesartan-and-hydrochlorothiazide/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Olmesartan and hydrochlorothiazide availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/olmesartan-and-hydrochlorothiazide/">Olmesartan and hydrochlorothiazide shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>